Only one of 41 patients did not have at least stable disease with cadonilimab plus chemoth ...

Trastuzumab pamirtecan, being developed under a 2023 partnership between BioNTech and DualityBio, elicited a 44.1% overall ...

Investigators sought to determine whether abemaciclib plus letrozole showed clinically meaningful activity in patients with advanced or recurrent endometrioid endometrial cancer.

A combination of Verzenio and letrozole has shown encouraging and lasting responses in patients with advanced or recurrent ...

For years, Kemi Doll, MD, a gynecologic oncologist at UW Medicine in Seattle, has been treating Black women with endometrial cancer. During that time, she has noticed some stark differences in how ...

Fertility-preserving hormonal therapy use for early-stage endometrial cancer increased from 5.2% in 2004 to 13.8% in 2020. Survival with that treatment was comparable to that with hysterectomy in ...